在现代医学的快速发展中，HER2基因突变越来越引起医务工作者和患者的关注。你是否了解，HER2的点突变可能隐藏在你身体的每一个角落，并可能影响你的健康状况？在对抗癌症和其他相关疾病的斗争中，HER2突变的作用不可小视。

作者 | 张祖盛创新药如何规避马库什专利？本文简单介绍了EGFR、三代EGFR抑制剂和侵权判断理论，并以阿美替尼和拉泽替尼是否侵犯奥希替尼化合物专利为例，详细说明了如何进行药品化合物专利规避。01EGFR结构、与肿瘤关系肿瘤和表皮生长因子受体（epi ...

The scales on a crocodile’s head develop differently than those on its body. The explanation lies in tissue mechanics.

Tina Willits, now 53, thought she had just two years to live. Today, she is cancer-free — and she wants the world to know about the treatment that saved her.

British drug maker AstraZeneca Plc (AZN.L, AZN) announced Monday that the European Commission has approved Tagrisso (osimertinib) to ...

Rostaporfin is under clinical development by TuHURA Biosciences and currently in Phase III for Metastatic Breast Cancer.

Amivantamab is under clinical development by Johnson & Johnson and currently in Phase I for Gastroesophageal (GE) Junction Carcinomas.

New DESTINY-Breast06 analysis showed trastuzumab deruxtecan doubled PFS versus chemotherapy in patients with rapid ...

Post hoc data from TAILORx show that adding an anthracycline to taxane-based chemotherapy benefits patients with HR-positive ...